financetom
STAA
financetom
/
Healthcare
/
STAA
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
STAAR Surgical CompanySTAA
USD
+0.49 (2.79%)
Jun 6, 2025, 4:00 PM - At close
USD
-0.02 (-0.08%)
Jun 6, 2025, 4:00 PM EDT - Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
Market Cap
885.49M
Revenue (ttm)
279.13M
Net Income (ttm)
-71.08M
Shares Out
49.51M
EPS (ttm)
-1.44
PE Ratio
n/a
Forward PE
n/a
Dividend
n/a
Ex-Dividend Date
n/a
Volume
918,657
Open
17.51
Previous Close
17.40
Day's Range
17.40 - 18.13
52-Week Range
13.50 - 49.86
Beta
0.61
Analysts
Hold
Price Target
27.17 (+51.92%)
Earnings Date
May 7, 2025
Description >

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.

The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery.

In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.

The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.

STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Copyright 2023-2025 - www.financetom.com All Rights Reserved